MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

P. de la Puente, B. Muz, A. Jin, F. Azab, M. Luderer, N. N. Salama, A. K. Azab

Research output: Contribution to journalLetterpeer-review

17 Scopus citations
Original languageEnglish
Article numbere399
JournalBlood cancer journal
Issue number2
StatePublished - 2016

Cite this